Another Reason to Study Your Biotech ETF’s Holdings
February 25, 2014 at 13:34 PM EST
Active followers of the biotechnology industry likely still remember the day in January when shares of Intercept Pharmaceuticals (NasdaqGM: ICPT) nearly quadrupled in a single trading session after trials for the company’s liver disease treatment proved successful. Investors in biotech exchange...